Cas no 1188153-49-2 (Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate)
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate
- Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate
- 2-Bromo-4-(4-trifluoromethyl-phenyl)-thiazole-5-carboxylic acid ethyl ester
- AG-A-38000
- AK-88237
- ANW-67431
- CTK6F8013
- KB-252583
- 5-Thiazolecarboxylic acid, 2-broMo-4-[4-(trifluoroMethyl)phenyl]-, ethyl ester
- Ethyl2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate
- ethyl 2-bromo-4-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylate
- CS-0061559
- 1188153-49-2
- MFCD11220991
- AKOS016006775
- DTXSID50694655
- W16944
- DB-061415
- AS-73558
-
- MDL: MFCD11220991
- Inchi: 1S/C13H9BrF3NO2S/c1-2-20-11(19)10-9(18-12(14)21-10)7-3-5-8(6-4-7)13(15,16)17/h3-6H,2H2,1H3
- InChI Key: GJROTGCXQSNRKG-UHFFFAOYSA-N
- SMILES: BrC1=NC(=C(C(=O)OCC)S1)C1C=CC(C(F)(F)F)=CC=1
Computed Properties
- Exact Mass: 378.94895g/mol
- Monoisotopic Mass: 378.94895g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 21
- Rotatable Bond Count: 5
- Complexity: 375
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 5.1
- Topological Polar Surface Area: 67.4?2
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A059003220-1g |
Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate |
1188153-49-2 | 95% | 1g |
$530.00 | 2023-09-04 | |
| TRC | E075530-50mg |
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate |
1188153-49-2 | 50mg |
$ 410.00 | 2022-06-05 | ||
| TRC | E075530-100mg |
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate |
1188153-49-2 | 100mg |
$ 680.00 | 2022-06-05 | ||
| Chemenu | CM189262-1g |
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate |
1188153-49-2 | 95% | 1g |
$580 | 2021-08-05 | |
| Chemenu | CM189262-1g |
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate |
1188153-49-2 | 95%+ | 1g |
$615 | 2023-02-18 | |
| eNovation Chemicals LLC | D761987-100mg |
5-Thiazolecarboxylic acid, 2-broMo-4-[4-(trifluoroMethyl)phenyl]-, ethyl ester |
1188153-49-2 | 95% | 100mg |
$335 | 2024-06-07 | |
| eNovation Chemicals LLC | D761987-250mg |
5-Thiazolecarboxylic acid, 2-broMo-4-[4-(trifluoroMethyl)phenyl]-, ethyl ester |
1188153-49-2 | 95% | 250mg |
$540 | 2024-06-07 | |
| Ambeed | A656236-1g |
Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate |
1188153-49-2 | 95+% | 1g |
$564.0 | 2024-04-25 | |
| A2B Chem LLC | AE28068-100mg |
Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate |
1188153-49-2 | 95% | 100mg |
$310.00 | 2024-04-20 | |
| A2B Chem LLC | AE28068-250mg |
Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate |
1188153-49-2 | 95% | 250mg |
$510.00 | 2024-04-20 |
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate Related Literature
-
Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
-
2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disordersJie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
-
Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
Additional information on Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate (CAS No. 1188153-49-2): A Comprehensive Overview
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate (CAS No. 1188153-49-2) is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound, characterized by its intricate molecular structure, presents a unique combination of functional groups that make it a promising candidate for various applications. The presence of a bromine atom, a trifluoromethyl group, and a thiazole core provides a rich scaffold for further chemical modifications and biological evaluations.
The thiazole moiety is particularly noteworthy due to its prevalence in biologically active molecules. Thiazole derivatives have been extensively studied for their antimicrobial, anti-inflammatory, and anticancer properties. In particular, the substitution pattern of the thiazole ring, as seen in this compound, can significantly influence its pharmacological activity. The 2-bromo substituent enhances the electrophilicity of the molecule, making it more reactive in cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions are pivotal in constructing complex molecular architectures, which is often required in drug discovery.
The 4-(4-(trifluoromethyl)-phenyl) group adds another layer of functionality to the molecule. The trifluoromethyl group is known for its ability to modulate lipophilicity and metabolic stability, which are critical factors in drug design. Additionally, the phenyl ring provides a hydrophobic pocket that can interact with biological targets. This combination of features makes Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate an attractive intermediate for synthesizing novel compounds with enhanced biological activity.
In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting specific enzymes and receptors involved in disease pathways. Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate has been explored as a precursor in the synthesis of inhibitors for enzymes such as kinases and proteases. For instance, thiazole derivatives have shown promise in inhibiting Janus kinases (JAKs), which are implicated in various inflammatory diseases. The bromine substituent on the thiazole ring allows for easy modification through transition-metal-catalyzed reactions, enabling the construction of diverse libraries of compounds for high-throughput screening.
The pharmaceutical industry has also been interested in this compound for its potential applications in oncology. Preclinical studies have indicated that certain thiazole derivatives exhibit inhibitory effects on tumor growth by interfering with key signaling pathways. The structural features of Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate make it a valuable building block for designing molecules that can selectively target cancer cells while minimizing side effects on healthy tissues.
Beyond pharmaceuticals, this compound has found utility in agrochemical research. The combination of a bromine atom and a trifluoromethyl group enhances the bioactivity of thiazole derivatives against various pests and pathogens. Researchers have been exploring its potential as a precursor for developing new-generation pesticides with improved efficacy and environmental safety.
The synthesis of Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate involves multi-step organic transformations that highlight the versatility of modern synthetic chemistry techniques. The process typically begins with the functionalization of readily available starting materials such as bromothiophenes and aromatic aldehydes. Palladium-catalyzed cross-coupling reactions play a crucial role in assembling the complex core structure of the molecule. These reactions not only provide efficient routes to the desired product but also allow for precise control over regioselectivity and stereochemistry.
The role of computational chemistry in optimizing synthetic routes cannot be overstated. Molecular modeling studies have been instrumental in predicting reaction outcomes and identifying optimal reaction conditions. By leveraging computational tools, chemists can accelerate the discovery process and minimize experimental trials.
In conclusion, Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate represents a fascinating example of how structural complexity can be harnessed to develop molecules with significant biological activity. Its unique combination of functional groups makes it a versatile intermediate for pharmaceutical and agrochemical applications. As research continues to uncover new therapeutic targets and synthetic methodologies, compounds like Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate will undoubtedly play a crucial role in shaping the future of drug discovery.
1188153-49-2 (Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate) Related Products
- 1206908-42-0(Methyl 2-bromo-4-(pyridin-4-yl)thiazole-5-carboxylate)
- 887267-75-6(Ethyl 2-amino-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate)
- 177328-30-2(Ethyl 2-bromo-4-phenylthiazole-5-carboxylate)
- 1206908-41-9(Methyl 2-bromo-4-(pyridin-3-yl)thiazole-5-carboxylate)
- 1188153-66-3(Ethyl 2-bromo-4-(4-cyanophenyl)thiazole-5-carboxylate)
- 1188123-06-9(Ethyl 2-bromo-4-(3,5-difluorophenyl)-thiazole-5-carboxylate)
- 1206908-03-3(Methyl 2-bromo-4-(4-fluorophenyl)thiazole-5-carboxylate)
- 1206908-21-5(Ethyl 4-(4-acetylphenyl)-2-bromothiazole-5-carboxylate)
- 1188153-86-7(Ethyl 2-bromo-4-(4-(tert-butyl)phenyl)thiazole-5-carboxylate)
- 72850-79-4(Ethyl 2-bromo-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate)